Javier Diez Selected Research

Javier Diez Research Topics

Disease

14	Fibrosis (Cirrhosis) 01/2022 - 12/2016
10	Heart Failure 01/2022 - 09/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 03/2002
4	Hypertension (High Blood Pressure) 01/2020 - 06/2010
4	Inflammation (Inflammations) 01/2019 - 03/2002
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2020 - 02/2015
3	Atherosclerosis 01/2019 - 12/2008
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2018 - 01/2018
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 09/2002
2	Hypertrophy 06/2010 - 09/2002
1	Coronary Disease (Coronary Heart Disease) 11/2021
1	Margins of Excision 01/2020
1	Neoplasms (Cancer) 01/2020
1	Obesity 01/2020
1	Vulvar Neoplasms (Vulvar Cancer) 01/2020
1	Heart Diseases (Heart Disease) 11/2019
1	Amyloidosis 11/2019
1	Cardiac Arrhythmias (Arrythmia) 11/2019
1	Myocarditis (Carditis) 06/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018
1	Cicatrix (Scar) 01/2010
1	Carotid Stenosis (Carotid Artery Stenosis) 08/2009
1	Essential Hypertension 09/2002
1	Vascular Remodeling 03/2002

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2014
7	CollagenIBA 01/2022 - 01/2010
5	Angiotensin IIIBA 01/2020 - 03/2002
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 01/2019
3	Procollagen Type IIBA 01/2022 - 01/2017
3	Natriuretic PeptidesIBA 11/2021 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	procollagen type I carboxy terminal peptide (PICP)IBA 01/2022 - 01/2019
2	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 01/2019
2	Collagen Type III (Type III Collagen)IBA 01/2022 - 01/2019
2	Galectin 3 (LGALS3)IBA 01/2022 - 01/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 01/2017
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Fibrillar CollagensIBA 11/2021
1	lycorineIBA 01/2020
1	bufalinIBA 01/2020
1	myosin-binding protein CIBA 01/2020
1	AlkaloidsIBA 01/2020
1	Amphibian VenomsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	SteroidsIBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	CholesterolIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	GadoliniumIBA 01/2018
1	Troponin T (Troponin T1)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	collagen type I trimeric cross-linked peptideIBA 01/2017
1	Troponin IIBA 01/2017
1	PeriostinIBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 01/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 12/2016
1	EnzymesIBA 12/2016
1	Diltiazem (Cardizem)FDA LinkGeneric 02/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2011
1	Superoxides (Superoxide)IBA 01/2011
1	cardiotrophin 1IBA 06/2010
1	AldosteroneIBA 06/2010
1	thiazolyl blueIBA 06/2010
1	Messenger RNA (mRNA)IBA 08/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2008
1	Metalloproteases (Metalloproteinases)IBA 12/2008
1	Fibrinogen (Factor I)FDA Link 01/2003
1	C-Reactive ProteinIBA 01/2003
1	von Willebrand FactorIBA 01/2003
1	Losartan (Cozaar)FDA LinkGeneric 09/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2002
1	Atenolol (Tenormin)FDA LinkGeneric 09/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2002
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2002

Therapy/Procedure

5	Therapeutics 01/2020 - 02/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Radiotherapy 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Immunomodulation 06/2018